Mass spectrometry-based abundance atlas of ABC transporters in human liver, gut, kidney, brain and skin.
Zubida M Al-MajdoubBrahim AchourNarciso CoutoMartyn HowardYasmine ElmorsiDaniel ScotcherSarah AlrubiaEman El-KhateebAreti-Maria VasilogianniNoura AlohaliSibylle NeuhoffLutz SchmittAmin Rostami-HodjeganJill BarberPublished in: FEBS letters (2020)
ABC transporters (ATP-binding cassette transporter) traffic drugs and their metabolites across membranes, making ABC transporter expression levels a key factor regulating local drug concentrations in different tissues and individuals. Yet, quantification of ABC transporters remains challenging because they are large and low-abundance transmembrane proteins. Here, we analysed 200 samples of crude and membrane-enriched fractions from human liver, kidney, intestine, brain microvessels and skin, by label-free quantitative mass spectrometry. We identified 32 (out of 48) ABC transporters: ABCD3 was the most abundant in liver, whereas ABCA8, ABCB2/TAP1 and ABCE1 were detected in all tissues. Interestingly, this atlas unveiled that ABCB2/TAP1 may have TAP2-independent functions in the brain and that biliary atresia (BA) and control livers have quite different ABC transporter profiles. We propose that meaningful biological information can be derived from a direct comparison of these data sets.
Keyphrases
- mass spectrometry
- resting state
- white matter
- label free
- high resolution
- liquid chromatography
- gene expression
- single cell
- poor prognosis
- functional connectivity
- air pollution
- cerebral ischemia
- soft tissue
- emergency department
- gas chromatography
- multiple sclerosis
- healthcare
- antibiotic resistance genes
- big data
- capillary electrophoresis
- electronic health record
- artificial intelligence
- social media
- dna binding
- anaerobic digestion